Evigrade catalog. Every drug is evaluated per drug-indication pair against international clinical guidelines
Evidence scale
Antiplatelet agents (low dose) / NSAIDs (analgesic dose)
B01AC06
2 indications
Amino acids and derivatives. Hepatoprotective agent
A16AA02
5 indications
Benzodiazepines. Short-to-medium-acting anxiolytics
N05BA12
3 indications
Class III antiarrhythmics (Vaughan Williams)
C01BD01
4 indications
Tricyclic antidepressants (TCA)
N06AA09
4 indications
Calcium channel blockers (dihydropyridines)
C08CA01
2 indications
Penicillins with extended spectrum
J01CA04
6 indications
Homeopathic medicines
V03AX-ANAFERON
4 indications
Homeopathic products (local classification)
V03AX-OSCILLO
4 indications
Homeopathic products (local classification)
V03AX-TENOTEN
4 indications
Direct oral anticoagulants (factor Xa inhibitors)
B01AF02
5 indications
Vitamins. Antioxidants
A11GA01
8 indications
HMG-CoA reductase inhibitors (statins)
C10AA05
4 indications
Macrolides
J01FA10
4 indications
Other immunostimulants (local classification)
L03AX-POLYOXIDONIUM
5 indications
Other immunostimulants
L03AX-OM85
3 indications
Selective beta-adrenergic blockers
C07AB07
4 indications
Inhaled corticosteroids (ICS)
R03BA02
5 indications
Mineral supplements. Calcium
A12AA-CALCIUM
4 indications
Mineral supplements. Calcium
A12AA04
5 indications
Angiotensin II receptor blocker
C09CA06
4 indications
ACE inhibitor
C09AA01
3 indications
Antiepileptics. Carboxamide derivatives
N03AF01
4 indications
Other metabolic agents (local classification)
V03AX-CEREBROLYSIN
2 indications
Second-generation antihistamines
R06AE07
7 indications
Other nervous system drugs. Parasympathomimetics
N07AX02
4 indications
Immunosuppressants. Calcineurin inhibitors
L04AD01
5 indications
Fluoroquinolone antibacterials
J01MA02
3 indications
Other psychostimulants and nootropics
N06BX06
4 indications
Macrolide antibiotic
J01FA09
4 indications
Antiplatelet agents – P2Y12 receptor inhibitors
B01AC04
3 indications
Sulfonamide-trimethoprim combination
J01EE01
5 indications
Vitamins. Regulator of calcium-phosphorus metabolism
A11CC05
7 indications
Other psychostimulants and nootropics (local classification)
N06BX-CORTEXIN
9 indications
Herbal anti-inflammatory agents
A07XA-CURCUMIN
5 indications
Vitamins. Haemopoietic stimulants
B03BA01
3 indications
Other metabolic agents (local classification)
A16AX-CYTOFLAVIN
3 indications
Direct thrombin inhibitor
B01AE07
3 indications
Other metabolic agents (local classification)
V03AX-ACTOVEGIN
3 indications
Glucocorticoids
H02AB02
3 indications
Anxiolytics. Benzodiazepine derivatives
N05BA01
6 indications
Non-steroidal anti-inflammatory drugs (NSAIDs)
M01AB05
4 indications
Tetracyclines
J01AA02
4 indications
Class III antiarrhythmic
C01BD07
3 indications
Myotropic antispasmodics
A03AD02
2 indications
Progestogens — pregnadiene derivatives
G03DB01
4 indications
Sodium-glucose co-transporter 2 inhibitors (SGLT2i)
A10BK03
4 indications
Angiotensin-converting enzyme inhibitors (ACEi)
C09AA02
4 indications
Homeopathic preparation marketed as an immunomodulator (local classification)
V03AX-ERGOFERON
4 indications
Selective serotonin reuptake inhibitors (SSRIs)
N06AB10
3 indications
Drugs for peptic ulcer and GORD. Proton pump inhibitors
A02BC05
6 indications
Liver therapy (local classification)
A05BA-ESSENTIALE
3 indications
Estrogens — natural and semisynthetic
G03CA03
4 indications
Estrogens. Natural and semisynthetic estrogens, plain
G03CA01
5 indications
Other metabolic agents (local RU classification)
V03AX-MEXIDOL
4 indications
Other anxiolytics (local classification)
N05BX-AFOBAZOLE
4 indications
Antifungals, triazole derivatives
J02AC01
3 indications
Selective serotonin reuptake inhibitors
N06AB03
3 indications
Inhaled corticosteroids (ICS)
R03BA05
3 indications
Vitamins. Haemopoietic stimulants
B03BB01
5 indications
Loop diuretics
C03CA01
7 indications
Aminoglycoside antibiotic
J01GB03
4 indications
Herbal agents for cognitive disorders
N06BX02
6 indications
Oral hypoglycemic agents. Sulfonylureas
A10BB01
4 indications
Chondroprotectors. Symptomatic slow-acting drugs for osteoarthritis (SYSADOA)
M01AX05
2 indications
Other psychostimulants and nootropics (local classification)
N06BX-GLYCINE
4 indications
Liver therapy (local classification, «hepatoprotectors»)
A05BA-PHOSPHOGLIV
4 indications
First-generation antipsychotics. Butyrophenone derivatives
N05AD01
5 indications
Thiazide diuretics
C03AA03
3 indications
Other dietary supplements. Bioactive peptides
V03AX-COLLAGEN
3 indications
Antidepressants. Other antidepressants of herbal origin
N06AX25
3 indications
Non-steroidal anti-inflammatory drugs (NSAIDs)
M01AE01
4 indications
Other oral cavity preparations (local classification)
R02AA-IMUDON
3 indications
Thiazide-like diuretics
C03BA11
2 indications
Other antivirals with claimed immunostimulant effect
J05AX05-INOSINE-PRANOBEX
3 indications
Insulins and analogues (general card; individual products require separate cards)
A10A
3 indications
Other topical nasal preparations (local classification)
R01AX-GRIPPFERON
4 indications
Interferons (suppositories, local classification)
L03AB05-VIFERON
4 indications
X-ray contrast media. Watersoluble nephrotropic low-osmolar iodinated agents
V08AB05
4 indications
Iron preparations. Antianaemic agents
B03AA-IRON-ORAL
4 indications
Other antivirals (local classification)
J05AX-KAGOCEL
4 indications
Systemic antimycotics. Imidazole derivatives
J02AB02
4 indications
Non-steroidal anti-inflammatory drugs (NSAIDs)
M01AB15
2 indications
Thyroid hormones
H03AA01
4 indications
Oxazolidinone antibiotic
J01XX08
4 indications
Psycholeptics. Lithium
N05AN01
4 indications
Second-generation antihistamines
R06AX13
6 indications
Angiotensin II receptor blockers (sartans)
C09CA01
3 indications
Carotenoids. Antioxidants for vision
S01XA-LUTEIN
3 indications
Mineral supplements. Macrominerals
A12CC-MAGNESIUM
5 indications
Other immunostimulants (local classification)
J05AX-CYCLOFERON
6 indications
Hypnotics. Melatonin receptor agonists
N05CH01
5 indications
Vitamins. γ-glutamyl carboxylase cofactor
B02BA-K2
3 indications
Analgesics and antipyretics. Pyrazolones
N02BB02
3 indications
Biguanides. Oral antihyperglycemic agents
A10BA02
5 indications
Antimetabolites, folic acid analogues
L01BA01
4 indications
Selective β1-adrenoceptor blockers
C07AB02
4 indications
Imidazole derivatives (antiprotozoal / antibacterial)
J01XD01
4 indications
Leukotriene receptor antagonists
R03DC03
3 indications
Natural opium alkaloids
N02AA01
3 indications
Antidotes, opioid receptor antagonists
V03AB15
1 indication
Intestinal antimicrobial
A07AX03
3 indications
Antiinflammatory and antirheumatic agents, non-steroids. Other NSAIDs
M01AX17
3 indications
Organic nitrate
C01DA02
4 indications
Second-generation fluoroquinolone
J01MA06
4 indications
Lipid-modifying agents. Omega-3 polyunsaturated fatty acids
C10AX06
4 indications
Proton pump inhibitors
A02BC01
4 indications
Neuraminidase inhibitors
J05AH02
2 indications
Posterior pituitary hormones
H01BB02
3 indications
Digestives. Multienzyme preparations
A09AA02
5 indications
Proton pump inhibitors
A02BC02
3 indications
Anilides. Analgesics and antipyretics
N02BE01
4 indications
Anxiolytics. Benzodiazepine derivatives
N05BA
3 indications
Other anxiolytics (local classification)
N05BX-PHENIBUT
5 indications
Antiepileptics. Barbiturates
N03AA02
4 indications
Vitamin K1. Haemostatics. Antagonist of indirect anticoagulants
B02BA01
4 indications
Old «nootropics» (local classification)
N06BX-PIRACETAM
7 indications
Combination nootropic (local classification)
N06BX-FEZAM
4 indications
Iodine therapy for thyroid function
H03CA01
4 indications
Glucocorticoids
H02AB06
7 indications
Gabapentinoids (antiepileptics)
N03AX16
4 indications
Probiotic microorganisms
A07FA-PROBIOTICS
10 indications
Progestogens — progesterone derivatives
G03DA04
5 indications
Non-selective beta blocker
C07AA05
5 indications
Vitamins. Coenzyme
A11HA02
5 indications
Atypical antipsychotics
N05AH04
4 indications
Antituberculous antibiotic
J04AB02
5 indications
Direct oral anticoagulants (factor Xa inhibitors)
B01AF01
5 indications
HMG-CoA reductase inhibitors (statins)
C10AA07
3 indications
Short-acting beta-2 adrenergic agonists (SABA)
R03AC02
7 indications
Mineral supplements. Trace elements
A12CE-SELENIUM
5 indications
GLP-1 receptor agonists
A10BJ06
4 indications
Selective serotonin reuptake inhibitors (SSRIs)
N06AB06
5 indications
Liver therapy. Herbal agent
A05BA03
5 indications
Drugs for functional bowel disorders. Antifoaming agents
A03AX13
4 indications
HMG-CoA reductase inhibitors (statins)
C10AA01
2 indications
Potassium-sparing diuretics (mineralocorticoid receptor antagonists)
C03DA01
4 indications
Alpha-adrenergic blockers for prostatic disorders
G04CA02
2 indications
Methylxanthine
R03DA04
3 indications
Antithyroid preparations. Sulfur-containing imidazole derivatives
H03BB02
4 indications
Other antivirals (local classification)
J05AX-TILORONE
5 indications
Other opioids
N02AX02
3 indications
Antifibrinolytics, amino acids
B02AA02
4 indications
Other cardiac preparations. Coenzyme Q10
C01EB-COQ10
5 indications
Other antivirals
J05AX13
4 indications
Bile acid preparations
A05AA02
5 indications
Antiepileptics. Fatty acid derivatives
N03AG01
5 indications
Angiotensin II receptor blockers (ARBs)
C09CA03
3 indications
Non-dihydropyridine calcium channel blocker
C08DA01
5 indications
Psychostimulants and nootropics. Other psychostimulants and nootropics
N06BX18
4 indications
Other antivirals (local classification)
J05AX-INGAVIRIN
4 indications
Vitamin K antagonist anticoagulants
B01AA03
3 indications
Mineral supplements. Trace elements
A12CB-ZINC
5 indications